IL-23 receptor (IL-23R) gene protects against pediatric Crohnʼs disease
Open Access
- 1 May 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 13 (5), 511-515
- https://doi.org/10.1002/ibd.20126
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease GeneScience, 2006
- Both IL-12p70 and IL-23 are synthesized during active Crohnʼs disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibodyInflammatory Bowel Diseases, 2006
- Expression of Interleukin-12-Related Cytokine Transcripts in Inflammatory Bowel Disease: Elevated Interleukin-23p19 and Interleukin-27p28 in Crohnʼs Disease But Not in Ulcerative ColitisInflammatory Bowel Diseases, 2005
- Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune InflammationThe Journal of Experimental Medicine, 2003
- Increased expression of interleukin 17 in inflammatory bowel diseaseGut, 2003
- A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23RThe Journal of Immunology, 2002
- Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12Immunity, 2000
- High-Throughput Single Nucleotide Polymorphism Genotyping by Fluorescent 5′ Exonuclease AssayBioTechniques, 1999
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseThe New England Journal of Medicine, 1997
- Course of ulcerative colitis: Analysis of changes in disease activity over yearsGastroenterology, 1994